Peroxisome proliferator activated receptor- agonist slows the progression of hypertension, attenuates plasma interleukin-6 levels and renal inflammatory markers in angiotensin II infused mice

PPAR Research

Volumn , Issue , 2012, Pages

  Wilson, Justin L ^a   Duan, Rong ^a   El Marakby, Ahmed ^b   Alhashim, Abdulmohsin ^b   Lee, Dexter L ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; CYTOCHROME P450 4A; FENOFIBRATE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HYPERTENSION; MALE; MOUSE; NEPHRITIS; NONHUMAN; PROTEIN EXPRESSION; TELEMETRY; TREATMENT DURATION;

EID: 84864925274     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/645969     Document Type: Article

References (37)

1. Lin H., Cheng C. F., Chen H. H., Role of PPAR and its agonist in renal diseases PPAR Research 2010 2010 6
2. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 1990 347 6294 645 650
3. Tugwood J. D., Issemann I., Anderson R. G., Bundell K. R., McPheat W. L., Green S., The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene EMBO Journal 1992 11 2 433 439
4. Delerive P., Martin-Nizard F., Chinetti G., Trottein F., Fruchart J. C., Najib J., Duriez P., Staels B., Peroxisome proliferator-activated receptor activators inhibit thrombin- induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway Circulation Research 1999 85 5 394 402 (Pubitemid 29409616)
5. Gervois P., Kleemann R., Pilon A., Percevault F., Koenig W., Staels B., Kooistra T., Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor- activator fenofibrate The Journal of Biological Chemistry 2004 279 16 16154 16160 (Pubitemid 38509307)
6. Devchand P. R., Keller H., Peters J. M., Vazquez M., Gonzalez F. J., Wahli W., The PPAR -leukotriene B4 pathway to inflammation control Nature 1996 384 6604 39 43 (Pubitemid 26374579)
7. Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I. P., Delerive P., Fadel A., Chinetti G., Fruchart J. C., Najib J., Maclouf J., Tedgui A., Activation of human aortic smooth-muscle cells is inhibited by PPAR but not by PPAR activators Nature 1998 393 6687 790 793 (Pubitemid 28299490)
8. Chinetti G., Gbaguidi F. G., Griglio S., Mallat Z., Antonucci M., Poulain P., Chapman J., Fruchart J. C., Tedgui A., Najib-Fruchart J., Staels B., CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors Circulation 2000 101 20 2411 2417 (Pubitemid 30329133)
9. Diep Q. N., Benkirane K., Amiri F., Cohn J. S., Endemann D., Schiffrin E. L., PPAR activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats Journal of Molecular and Cellular Cardiology 2004 36 2 295 304 (Pubitemid 38202358)
10. Marx N., Mackman N., Schnbeck U., Yilmaz N., Hombach V., Libby P., Plutzky J., PPAR activators inhibit tissue factor expression and activity in human monocytes Circulation 2001 103 2 213 219 (Pubitemid 32095405)
11. Zhou Y., Luo P., Chang H. H., Huang H., Yang T., Dong Z., Wang C. Y., Wang M. H., Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension Kidney International 2008 74 8 1040 1048
12. Vera T., Taylor M., Bohman Q., Flasch A., Roman R. J., Stec D. E., Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice Hypertension 2005 45 4 730 735 (Pubitemid 40418373)
13. Duan S. Z., Usher M. G., Mortensen R. M., PPARs: the vasculature, inflammation and hypertension Current Opinion in Nephrology and Hypertension 2009 18 2 128 133
14. Newaz M. A., Ranganna K., Oyekan A. O., Relationship between PPAR activation and NO on proximal tubular Na + transport in the rat BMC Pharmacology 2004 4, article 1 1 9
15. Williams J. M., Zhao X., Wang M. H., Imig J. D., Pollock D. M., Peroxisome proliferator-activated receptor- activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade Hypertension 2005 46 2 366 371 (Pubitemid 41099171)
16. Zhou Y., Huang H., Chang H. H., Du J., Jing F. W., Wang C. Y., Wang M. H., Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats Journal of Pharmacology and Experimental Therapeutics 2006 317 1 11 18
17. Lee D. L., Wilson J. L., Duan R., Hudson T., El-Marakby A., Peroxisome Proliferator Activated Receptoralpha activation decreases mean arterial pressure, plasma interleukin-6 and COX-2, while increasing renal CYP4A expression in an acute model of DOCA-salt hypertension PPAR Research 2011 2011 7
18. Diep Q. N., Amiri F., Touyz R. M., Cohn J. S., Endemann D., Neves M. F., Schiffrin E. L., PPAR activator effects on Ang II-induced vascular oxidative stress and inflammation Hypertension 2002 40 6 866 871 (Pubitemid 35434908)
19. Zhao X., Pollock D. M., Inscho E. W., Zeldin D. C., Imig J. D., Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension Hypertension 2003 41 3 709 714 (Pubitemid 36314579)
20. Funakoshi Y., Ichiki T., Ito K., Takeshita A., Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells Hypertension 1999 34 1 118 125 (Pubitemid 29325729)
21. Han Y., Runge M. S., Brasier A. R., Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor- b transcription factors Circulation Research 1999 84 6 695 703 (Pubitemid 29157337)
22. Kranzhfer R., Schmidt J., Pfeiffer C. A. H., Hagl S., Libby P., Kbler W., Angiotensin induces inflammatory activation of human vascular smooth muscle cells Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 7 1623 1629 (Pubitemid 29323820)
23. Ruiz-Ortega M., Rupérez M., Lorenzo O., Esteban V., Blanco J., Mezzano S., Egido J., Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney Kidney International, Supplement 2002 62 82 S12 S22
24. Lee D. L., Sturgis L. C., Labazi H., Osborne J. B., Fleming C., Pollock J. S., Manhiani M., Imig J. D., Brands M. W., Angiotensin II hypertension is attenuated in interleukin-6 knockout mice American Journal of Physiology 2006 290 3 H935 H940
25. Ruiz-Ortega M., Rupérez M., Esteban V., Rodrguez-Vita J., Snchez-Lpez E., Carvajal G., Egido J., Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases Nephrology Dialysis Transplantation 2006 21 1 16 20 (Pubitemid 43057101)
26. Bakhle Y. S., Botting R. M., Cyclooxygenase-2 and its regulation in inflammation Mediators of Inflammation 1996 5 5 305 323 (Pubitemid 26395396)
27. DeWitt D. L., Smith W. L., Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence Proceedings of the National Academy of Sciences of the United States of America 1988 85 5 1412 1416
28. Yang T., Sun D., Huang Y. G., Smart A., Briggs J. P., Schnermann J. B., Differential regulation of COX-2 expression in the kidney by lipopolysaccharide: role of CD14 American Journal of Physiology 1999 277 1 F10 F16
29. Harris R. C., Breyer M. D., Physiological regulation of cyclooxygenase-2 in the kidney American Journal of Physiology 2001 281 1 F1 F11
30. Jaimes E. A., Tian R. X., Pearse D., Raij L., Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species Kidney International 2005 68 5 2143 2153 (Pubitemid 43117788)
31. Grasso E., Longo V., Coceani F., Gervasi P. G., Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle Biochimica et Biophysica Acta 2005 1722 2 116 123 (Pubitemid 40299001)
32. Zhao X., Quigley J. E., Yuan J., Wang M. H., Zhou Y., Imig J. D., PPAR- activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats American Journal of Physiology 2006 290 6 H2187 H2195
33. Zhao X., Pollock D. M., Inscho E. W., Zeldin D. C., Imig J. D., Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension Hypertension 2003 41 3 709 714 (Pubitemid 36314579)
34. Zhao X., Dey A., Romanko O. P., Stepp D. W., Wang M. H., Zhou Y., Jin L., Pollock J. S., Webb R. C., Imig J. D., Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats American Journal of Physiology 2005 288 1 R188 R196
35. Newaz M., Blanton A., Fidelis P., Oyekan A., NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR) -mediated cardiovascular effects Mutation Research 2005 579 1-2 163 171 (Pubitemid 41540140)
36. Delerive P., Fruchart J. C., Staels B., Peroxisome proliferator-activated receptors in inflammation control Journal of Endocrinology 2001 169 3 453 459 (Pubitemid 32536978)
37. Poynter M. E., Daynes R. A., Peroxisome proliferator-activated receptor activation modulates cellular redox status, represses nuclear factor- B signaling, and reduces inflammatory cytokine production in aging The Journal of Biological Chemistry 1998 273 49 32833 32841 (Pubitemid 28557672)